English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Biomarker in der Depressionsbehandlung: mehr als nur Worte? [Biomarkers in clinical depression treatment: more than words?]

MPS-Authors
/persons/resource/persons141840

Breitenstein,  Barbara
external;
Max Planck Institute of Psychiatry, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Bosch, O. G., & Breitenstein, B. (2015). Biomarker in der Depressionsbehandlung: mehr als nur Worte? [Biomarkers in clinical depression treatment: more than words?]. ZEITSCHRIFT FUR PSYCHIATRIE PSYCHOLOGIE UND PSYCHOTHERAPIE, 63(4), 217-232. doi:10.1024/1661-4747/a000244.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0029-B02D-3
Abstract
Diagnosis of depression relies on categorical classification systems, encompassing heterogeneous and partly opposing symptoms with still unresolved pathophysiology. However, the diagnostic process and the treatment selection still occur exclusively by means of verbal communication. To date, characterization of pathophysiology and treatment mechanisms in depression using biomarkers and genetic testing promises a more valid and thus more effective therapy management. At present, diverse methods such as genetic testing, proteomic and metabolomic profiling, neuroendocrine and electrophysiological parameters, and multimodal neuroimaging, have revealed first potentially useful biomarkers of depression. From some of these, biological models of depression have been established, involving the diathesis-stress model, the serotonin model, and frontocingulate dysfunction model of depression. To date, guidelines which integrate objectively assessable biomarkers into regular clinical depression treatment are still lacking. Until laboratory data, i.e. gene tests and biomarkers find their way into clinical practice, language will have the final say in depression treatment.